Stefani Samples
Stefani Samples has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Easton
Department of Pediatrics, Children's Hospital of Georgia, Medical College of Georgia, Augusta, GA, USA
1 shared publication Anastasios Polimenakos
Department of Pediatric Cardiothoracic Surgery, Children's Hospital of Georgia, Medical College of Georgia, Georgia Regents University, Augusta, GA, USA
1 shared publicationDennis Ownby
Department of Pediatrics, Section of Allergy-Immunology, Georgia Regents University, Augusta, Georgia
1 shared publicationHenry Wiles
Department of Pediatric Cardiology, Georgia Regents University, Augusta, Georgia; and
1 shared publicationKatrina Gleditsch
Department of Pediatrics, Children's Hospital of Georgia, Medical College of Georgia, Georgia Regents University, Augusta, GA, USA
1 shared publicationNirupma Sharma
Department of Pediatrics, Section of General Medicine, and
1 shared publication
Latest Publications
- 1 March 2016
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 6 (3) , 183-186
Pediatric Pesticide Poisoning: A Clinical Challenge
- 1 March 2016
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 6 (3) , 183-186
Pediatric Pesticide Poisoning: A Clinical Challenge
- 14 December 2015
- Published by Springer Nature in Pediatric Cardiology
- Vol. 37 (1) , 208-211
Intrapericardial NUT Midline Carcinoma: Unusual Presentation of a Rare Tumor and Literature Review with Management Considerations
Rearrangements in the nuclear protein in testis (NUT) gene cause carcinomas that represent a rare but aggressive tumor type that often present at advanced stages in midline structures. Survival rarely exceeds 12 months from the time of diagnosis. There have been no reports of a primary cardiac presentation, and few studies have reported on the numerous treatment strategies. Given their aggressive and invasive nature, NUT midline carcinomas present a therapeutic dilemma. Treatment may include surgical resection, chemotherapy, or radiotherapy, but no consistently successful treatment has been established. Surgical resection is indicated to reduce symptomatic mass effect whenever present. Novel therapies with bromodomain extra-terminal inhibitors may be associated with potential survival benefit. Here, we describe an unusual presentation of this tumor. Literature review with management considerations is underlying.
- 14 December 2015
- Published by Springer Nature in Pediatric Cardiology
- Vol. 37 (1) , 208-211
Intrapericardial NUT Midline Carcinoma: Unusual Presentation of a Rare Tumor and Literature Review with Management Considerations
Rearrangements in the nuclear protein in testis (NUT) gene cause carcinomas that represent a rare but aggressive tumor type that often present at advanced stages in midline structures. Survival rarely exceeds 12 months from the time of diagnosis. There have been no reports of a primary cardiac presentation, and few studies have reported on the numerous treatment strategies. Given their aggressive and invasive nature, NUT midline carcinomas present a therapeutic dilemma. Treatment may include surgical resection, chemotherapy, or radiotherapy, but no consistently successful treatment has been established. Surgical resection is indicated to reduce symptomatic mass effect whenever present. Novel therapies with bromodomain extra-terminal inhibitors may be associated with potential survival benefit. Here, we describe an unusual presentation of this tumor. Literature review with management considerations is underlying.
- 1 July 2014
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 4 (4) , 251-255
New Diagnosis of Common Variable Immunodeficiency in a 12-Year-Old With Pneumonia: An Illustrative Case
- 1 July 2014
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 4 (4) , 251-255
New Diagnosis of Common Variable Immunodeficiency in a 12-Year-Old With Pneumonia: An Illustrative Case